AF
LLY icon

Arrow Financial’s Eli Lilly LLY Stock Holding History

Arrow Financial’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.31M Sell
4,681
-262
-5% -$266K 0.43% 41
2025
Q4 		$5.31M Sell
4,943
-291
-6% -$278K 0.53% 34
2025
Q3 		$3.99M Sell
5,234
-10
-0.2% -$7.44K 0.41% 40
2025
Q2 		$4.09M Buy
5,244
+103
+2% +$80K 0.43% 42
2025
Q1 		$4.25M Sell
5,141
-3,428
-40% -$2.85M 0.47% 39
2024
Q4 		$6.62M Sell
8,569
-157
-2% -$130K 0.63% 32
2024
Q3 		$7.73M Sell
8,726
-3
-0% -$2.7K 0.71% 32
2024
Q2 		$7.9M Buy
8,729
+161
+2% +$129K 0.77% 29
2024
Q1 		$6.67M Buy
8,568
+853
+11% +$607K 0.66% 32
2023
Q4 		$4.5M Buy
7,715
+1,966
+34% +$1.15M 0.47% 51
2023
Q3 		$3.09M Buy
5,749
+2,405
+72% +$1.24M 0.36% 60
2023
Q2 		$1.57M Buy
3,344
+1,104
+49% +$463K 0.19% 85
2023
Q1 		$769K Hold
2,240
– – 0.1% 116
2022
Q4 		$820K Sell
2,240
-35
-2% -$12.4K 0.11% 114
2022
Q3 		$736K Sell
2,275
-50
-2% -$15.8K 0.11% 110
2022
Q2 		$754K Sell
2,325
-508
-18% -$152K 0.1% 112
2022
Q1 		$811K Hold
2,833
– – 0.1% 117
2021
Q4 		$782K Sell
2,833
-52
-2% -$13.2K 0.09% 116
2021
Q3 		$667K Sell
2,885
-35
-1% -$8.64K 0.09% 124
2021
Q2 		$670K Sell
2,920
-80
-3% -$16.1K 0.09% 127
2021
Q1 		$561K Sell
3,000
-165
-5% -$32.3K 0.07% 130
2020
Q4 		$534K Hold
3,165
– – 0.1% 116
2020
Q3 		$468K Sell
3,165
-100
-3% -$15.5K 0.1% 117
2020
Q2 		$536K Sell
3,265
-70
-2% -$10.7K 0.12% 115
2020
Q1 		$462K Sell
3,335
-150
-4% -$20.6K 0.11% 116
2019
Q4 		$458K Sell
3,485
-1,860
-35% -$216K 0.09% 124
2019
Q3 		$598K Sell
5,345
-2,175
-29% -$242K 0.12% 114
2019
Q2 		$833K Hold
7,520
– – 0.18% 101
2019
Q1 		$975K Buy
7,520
+2,063
+38% +$251K 0.23% 93
2018
Q4 		$632K Sell
5,457
-128
-2% -$14.3K 0.16% 107
2018
Q3 		$599K Buy
5,585
+40
+0.7% +$4K 0.13% 125
2018
Q2 		$474K Buy
5,545
+40
+0.7% +$3.29K 0.11% 134
2018
Q1 		$426K Hold
5,505
– – 0.1% 136
2017
Q4 		$464K Hold
5,505
– – 0.11% 130
2017
Q3 		$471K Sell
5,505
-100
-2% -$8.2K 0.11% 128
2017
Q2 		$461K Hold
5,605
– – 0.11% 133
2017
Q1 		$472K Hold
5,605
– – 0.12% 129
2016
Q4 		$412K Sell
5,605
-267
-5% -$19.9K 0.1% 128
2016
Q3 		$472K Sell
5,872
-100
-2% -$8K 0.12% 123
2016
Q2 		$471K Buy
5,972
+145
+2% +$10.9K 0.12% 123
2016
Q1 		$419K Sell
5,827
-55
-0.9% -$4.16K 0.11% 125
2015
Q4 		$496K Hold
5,882
– – 0.13% 113
2015
Q3 		$493K Sell
5,882
-100
-2% -$8.44K 0.14% 116
2015
Q2 		$500K Sell
5,982
-300
-5% -$22.9K 0.14% 126
2015
Q1 		$456K Sell
6,282
-247
-4% -$17.6K 0.12% 137
2014
Q4 		$451K Sell
6,529
-1,280
-16% -$86.4K 0.12% 132
2014
Q3 		$507K Sell
7,809
-475
-6% -$30.1K 0.14% 136
2014
Q2 		$515K Buy
8,284
+9
+0.1% +$537 0.14% 138
2014
Q1 		$488K Buy
8,275
+330
+4% +$18.4K 0.14% 139
2013
Q4 		$405K Sell
7,945
-25
-0.3% -$1.25K 0.12% 135
2013
Q3 		$401K Buy
7,970
+35
+0.4% +$1.83K 0.12% 130
2013
Q2 		$390K Buy
+7,935
New +$432K 0.12% 128

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arrow Financial's LLY Position: Q1 2026 in Review

Arrow Financial reduced its Eli Lilly (LLY) stake by 5.3% in Q1 2026, selling an estimated $266K and leaving 4,681 shares worth $4.31M. The position accounts for 0.43% of the portfolio, ranked #41.

Arrow Financial first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.9M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Arrow Financial held 4,681 shares of Eli Lilly worth $4.31M as of Q1 2026.
  • Arrow Financial sold 262 Eli Lilly shares in Q1 2026, an estimated $266K.
  • Eli Lilly made up 0.43% of Arrow Financial's portfolio in Q1 2026, its #41 holding.
  • Arrow Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Arrow Financial's Eli Lilly position peaked at $7.9M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Arrow Financial's 13F filing for Q1 2026, filed 11 May 2026.